Pfizer, Government agree on indefinite, free Diflucan plan
More than two million free doses of the anti-fungal Diflucan used to treat AIDS related fungal infections have been dispensed in South Africa during a groundbreaking two-year partnership between government and pharmaceutical giant Pfizer, manufacturer of the drug.
Another spin-off of the initiative is that more than 10 000 health care professionals have been trained under the project and in mid-November Pfizer announced that the programme would be extended in South Africa with “no dollar or time limit.”
The Diflucan Partnership programme is the only one of its kind in South Africa and a remarkable one given the government’s history of scepticism with regard to accepting drug donations. The reason for this says Advocate Patricia Lambert, legal advisor to the Minister of Health and chairperson of the Diflucan Partnership working group, is because it is not sustainable to plan or run a country’s health sector on donations which could dry up or that are based on time frames.
“It was with some trepidation that in the year 2000 we began to negotiate how this particular partnership programme would work around the lines of a donation programme. What I have been able to see is that those things that made us nervous and wary of one another and of how we would manage this process have been solved, we have moved with the speed that is unusual, and that is to be welcomed,” said Ms Lambert.
The aim of the Diflucan partnership programme is to provide the drug free of charge to government which in turn makes it available to people living with HIV and AIDS in South Africa and who rely on the country’s public health facilities.
Diflucan is an anti-fungal drug used to treat most common infections associated with diseases like cryptococcal meningitis and oesophageal candidiasis. These infections affect up to 40 percent of all infected people.
“Diflucan will be available for as long as South African patients require it. Through this gesture, we hope that we are able to make people’s lives better, that we are bale to prolong their quality of life and that we are able to continue to build capacity in our health care workers who care for patients every day,” said Ms Lambert.
Mr John Kearney, Chief Executive Officer of Pfizer, South Africa, said that to date, 317 health centres were administering the drug to their clients, and 10 000 workers have been trained in that regard.
Mr Kearney added that patients were aware that Diflucan is not an anti-retroviral and is used to manage opportunistic infections.
The Minister of Health, Dr Manto Tshabalala-Msimang said the extension of the agreement had enabled government to include South Africa’s rural areas as part of the programme.
She added that the success of the initiative had inspired the introduction of similar programmes in nine other African countries. In South Africa, the value of the donation is estimated to be in the region of R40-million.
The timing of the announcement of the renewed partnership is fitting, considering that in two weeks, the world will once again be paying tribute to the millions around the globe who have died of AIDS, and just as importantly to the millions who live infected and affected by HIV and AIDS.
Author
Republish this article
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Unless otherwise noted, you can republish our articles for free under a Creative Commons license. Here’s what you need to know:
You have to credit Health-e News. In the byline, we prefer “Author Name, Publication.” At the top of the text of your story, include a line that reads: “This story was originally published by Health-e News.” You must link the word “Health-e News” to the original URL of the story.
You must include all of the links from our story, including our newsletter sign up link.
If you use canonical metadata, please use the Health-e News URL. For more information about canonical metadata, click here.
You can’t edit our material, except to reflect relative changes in time, location and editorial style. (For example, “yesterday” can be changed to “last week”)
You have no rights to sell, license, syndicate, or otherwise represent yourself as the authorized owner of our material to any third parties. This means that you cannot actively publish or submit our work for syndication to third party platforms or apps like Apple News or Google News. Health-e News understands that publishers cannot fully control when certain third parties automatically summarise or crawl content from publishers’ own sites.
You can’t republish our material wholesale, or automatically; you need to select stories to be republished individually.
If you share republished stories on social media, we’d appreciate being tagged in your posts. You can find us on Twitter @HealthENews, Instagram @healthenews, and Facebook Health-e News Service.
You can grab HTML code for our stories easily. Click on the Creative Commons logo on our stories. You’ll find it with the other share buttons.
If you have any other questions, contact info@health-e.org.za.
Pfizer, Government agree on indefinite, free Diflucan plan
by Khopotso Bodibe, Health-e News
November 19, 2002